{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:21:55Z","timestamp":1792783315548,"version":"4.5.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Western Sydney University","id":[{"id":"https:\/\/ror.org\/03t52dk35","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"DOI":"10.1007\/s12325-026-03799-7","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:37:33Z","timestamp":1791268653000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Questionable Evidence for Berberine in Polyendocrine Metabolic Ovarian Syndrome: An Integrity-Based Reappraisal"],"prefix":"10.1007","author":[{"given":"Eshani","family":"Perera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangeline","family":"Mantzioris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Scannell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibhuti","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Flannagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3363-9199","authenticated-orcid":false,"given":"Carolyn","family":"Ee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"3799_CR1","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/S0140-6736(26)00717-8","volume":"407","author":"HJ Teede","year":"2026","unstructured":"Teede HJ, Khomami MB, Morman R, Laven JSE, Joham AE, Costello MF, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026;407:2329\u201339.","journal-title":"Lancet"},{"issue":"2","key":"3799_CR2","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","volume":"189","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endo. 2023;189(2):G43-g64.","journal-title":"Eur J Endo"},{"issue":"16","key":"3799_CR3","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.033572","volume":"13","author":"CT Tay","year":"2024","unstructured":"Tay CT, Mousa A, Vyas A, Pattuwage L, Tehrani FR, Teede H. 2023 international evidence-based polycystic ovary syndrome guideline update: insights from a systematic review and meta-analysis on elevated clinical cardiovascular disease in polycystic ovary syndrome. J Am Heart Assoc. 2024;13(16):e033572.","journal-title":"J Am Heart Assoc"},{"issue":"Suppl 3","key":"3799_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/dom.16422","volume":"27","author":"S Saadati","year":"2025","unstructured":"Saadati S, Mason T, Godini R, Vanky E, Teede H, Mousa A. Metformin use in women with polycystic ovary syndrome (PCOS): opportunities, benefits, and clinical challenges. Diabetes Obes Metab. 2025;27(Suppl 3):31\u201347.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"3799_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00404-020-05450-4","volume":"301","author":"M Rondanelli","year":"2020","unstructured":"Rondanelli M, Infantino V, Riva A, Petrangolini G, Faliva MA, Peroni G, et al. Polycystic ovary syndrome management: a review of the possible amazing role of berberine. Arch Gynecol Obstet. 2020;301(1):53\u201360.","journal-title":"Arch Gynecol Obstet"},{"key":"3799_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2532935","volume":"2018","author":"MF Li","year":"2018","unstructured":"Li MF, Zhou XM, Li XL. The effect of berberine on polycystic ovary syndrome patients with insulin resistance (PCOS-IR): a meta-analysis and systematic review. Evid Based Complement Alternat Med. 2018;2018:2532935.","journal-title":"Evid Based Complement Alternat Med"},{"key":"3799_CR7","doi-asserted-by":"publisher","first-page":"7918631","DOI":"10.1155\/2019\/7918631","volume":"2019","author":"L Xie","year":"2019","unstructured":"Xie L, Zhang D, Ma H, He H, Xia Q, Shen W, et al. The effect of berberine on reproduction and metabolism in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized control trials. Evid Based Complement Alternat Med. 2019;2019:7918631.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"2","key":"3799_CR8","first-page":"14","volume":"21","author":"AR Gaby","year":"2022","unstructured":"Gaby AR. Is there an epidemic of research fraud in natural medicine? Integr Med (Encinitas). 2022;21(2):14\u20138.","journal-title":"Integr Med (Encinitas)"},{"key":"3799_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102717","author":"A Mousa","year":"2024","unstructured":"Mousa A, Flanagan M, Tay CT, Norman RJ, Costello M, Li W, et al. Research Integrity in Guidelines and evIDence synthesis (RIGID): a framework for assessing research integrity in guideline development and evidence synthesis. eClinicalMedicine. 2024. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102717.","journal-title":"eClinicalMedicine"},{"key":"3799_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s41073-023-00130-8","volume":"8","author":"BW Mol","year":"2023","unstructured":"Mol BW, Lai S, Rahim A, Bordewijk EM, Wang R, Eekelen Rv, et al. A checklist to assess Trustworthiness in RAndomised Controlled Trials (TRACT checklist). Res Integr Peer Rev. 2023;8:6.","journal-title":"Res Integr Peer Rev"},{"key":"3799_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"1","key":"3799_CR12","volume":"14","author":"N Mishra","year":"2022","unstructured":"Mishra N, Verma R, Jadaun P. Study on the effect of berberine, myoinositol, and metformin in women with polycystic ovary syndrome: a prospective randomised study. Cureus. 2022;14(1):e21781.","journal-title":"Cureus"},{"key":"3799_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1269605","volume":"14","author":"F Di Pierro","year":"2023","unstructured":"Di Pierro F, Sultana R, Eusaph AZ, Abrar S, Bugti M, Afridi F, et al. Effect of berberine phytosome on reproductive, dermatologic, and metabolic characteristics in women with polycystic ovary syndrome: a controlled, randomized, multi-centric, open-label clinical trial. Front Pharmacol. 2023;14:1269605.","journal-title":"Front Pharmacol"},{"issue":"3","key":"3799_CR14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/cen.12294","volume":"80","author":"Y An","year":"2014","unstructured":"An Y, Sun Z, Zhang Y, Liu B, Guan Y, Lu M. The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment. Clin Endocrinol (Oxf). 2014;80(3):425\u201331.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"3799_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1530\/EJE-11-0616","volume":"166","author":"W Wei","year":"2012","unstructured":"Wei W, Zhao H, Wang A, Sui M, Liang K, Deng H, et al. A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome. Eur J Endocrinol. 2012;166(1):99\u2013105.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"3799_CR16","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1210\/clinem\/dgad762","volume":"109","author":"V Fitz","year":"2024","unstructured":"Fitz V, Graca S, Mahalingaiah S, Liu J, Lai L, Butt A. Inositol for polycystic ovary syndrome: a systematic review and meta-analysis to inform the 2023 update of the International Evidence-Based PCOS Guidelines. J Clin Endocrinol Metab. 2024;109(6):1630\u201355.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03799-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03799-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03799-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:37:34Z","timestamp":1791268654000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-026-03799-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":16,"alternative-id":["3799"],"URL":"https:\/\/doi.org\/10.1007\/s12325-026-03799-7","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"24 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Eshani Perera, Evangeline Mantzioris, Lisa Moran, Nicole Scannell, Anthony Villani, Vibhuti Rao, Madeline Flannagan, and Carolyn Ee have nothing to disclose. Aya Mousa is an Editorial Board member of\n                      Advances in Therapy\n                      . Aya Mousa was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. The authors declare that no permission was required to use the Research Integrity in Guidelines and Evidence Synthesis (RIGID) framework or Trustworthiness in Randomised Controlled Trials (TRACT) checklist.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}